Annual Revenue
$2.39 B
+$181.30 M+8.20%
December 31, 2023
Summary
- As of February 8, 2025, AMRX annual revenue is $2.39 billion, with the most recent change of +$181.30 million (+8.20%) on December 31, 2023.
- During the last 3 years, AMRX annual revenue has risen by +$401.08 million (+20.13%).
- AMRX annual revenue is now at all-time high.
Performance
AMRX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$702.47 M
+$688.00 K+0.10%
September 30, 2024
Summary
- As of February 8, 2025, AMRX quarterly revenue is $702.47 million, with the most recent change of +$688.00 thousand (+0.10%) on September 30, 2024.
- Over the past year, AMRX quarterly revenue has increased by +$82.43 million (+13.29%).
- AMRX quarterly revenue is now at all-time high.
Performance
AMRX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$2.68 B
+$82.43 M+3.17%
September 30, 2024
Summary
- As of February 8, 2025, AMRX TTM revenue is $2.68 billion, with the most recent change of +$82.43 million (+3.17%) on September 30, 2024.
- Over the past year, AMRX TTM revenue has increased by +$294.04 million (+12.32%).
- AMRX TTM revenue is now at all-time high.
Performance
AMRX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
AMRX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.2% | +13.3% | +12.3% |
| 3 y3 years | +20.1% | +17.3% | +15.9% |
| 5 y5 years | +43.9% | +17.3% | +15.9% |
AMRX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +14.3% | at high | +41.2% | at high | +28.0% |
| 5 y | 5-year | at high | +47.2% | at high | +76.8% | at high | +64.8% |
| alltime | all time | at high | +135.1% | at high | +175.8% | at high | +931.4% |
Amneal Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $702.47 M(+0.1%) | $2.68 B(+3.2%) |
| Jun 2024 | - | $701.78 M(+6.5%) | $2.60 B(+4.1%) |
| Mar 2024 | - | $659.19 M(+6.8%) | $2.50 B(+4.2%) |
| Dec 2023 | $2.39 B(+8.2%) | $616.98 M(-0.5%) | $2.39 B(+0.3%) |
| Sep 2023 | - | $620.04 M(+3.5%) | $2.39 B(+3.2%) |
| Jun 2023 | - | $599.05 M(+7.4%) | $2.31 B(+1.7%) |
| Mar 2023 | - | $557.54 M(-8.6%) | $2.27 B(+2.7%) |
| Dec 2022 | $2.21 B(+5.7%) | $609.76 M(+11.8%) | $2.21 B(+3.4%) |
| Sep 2022 | - | $545.56 M(-2.5%) | $2.14 B(+0.8%) |
| Jun 2022 | - | $559.36 M(+12.4%) | $2.12 B(+1.2%) |
| Mar 2022 | - | $497.63 M(-7.3%) | $2.10 B(+0.2%) |
| Dec 2021 | $2.09 B(+5.1%) | $536.90 M(+1.6%) | $2.09 B(+1.3%) |
| Sep 2021 | - | $528.59 M(-1.2%) | $2.07 B(+0.5%) |
| Jun 2021 | - | $535.08 M(+8.5%) | $2.06 B(+3.5%) |
| Mar 2021 | - | $493.11 M(-3.3%) | $1.99 B(-0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $1.99 B(+22.5%) | $510.03 M(-1.8%) | $1.99 B(+6.0%) |
| Sep 2020 | - | $519.29 M(+11.8%) | $1.88 B(+8.1%) |
| Jun 2020 | - | $464.66 M(-6.8%) | $1.74 B(+3.6%) |
| Mar 2020 | - | $498.53 M(+25.5%) | $1.68 B(+3.2%) |
| Dec 2019 | $1.63 B(-2.2%) | $397.33 M(+5.0%) | $1.63 B(-5.8%) |
| Sep 2019 | - | $378.28 M(-6.5%) | $1.73 B(-5.4%) |
| Jun 2019 | - | $404.64 M(-9.3%) | $1.82 B(-0.5%) |
| Mar 2019 | - | $446.12 M(-10.3%) | $1.83 B(+10.3%) |
| Dec 2018 | $1.66 B(+60.9%) | $497.53 M(+4.4%) | $1.66 B(+14.0%) |
| Sep 2018 | - | $476.49 M(+15.2%) | $1.46 B(+17.9%) |
| Jun 2018 | - | $413.79 M(+50.4%) | $1.24 B(+14.2%) |
| Mar 2018 | - | $275.19 M(-6.2%) | $1.08 B(+34.1%) |
| Dec 2017 | $1.03 B(+1.5%) | $293.37 M(+15.2%) | $807.97 M(+57.0%) |
| Sep 2017 | - | $254.73 M(-2.0%) | $514.60 M(+98.0%) |
| Jun 2017 | - | $259.87 M | $259.87 M |
| Dec 2016 | $1.02 B | - | - |
FAQ
- What is Amneal Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals annual revenue year-on-year change?
- What is Amneal Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals quarterly revenue year-on-year change?
- What is Amneal Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals TTM revenue year-on-year change?
What is Amneal Pharmaceuticals annual revenue?
The current annual revenue of AMRX is $2.39 B
What is the all time high annual revenue for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high annual revenue is $2.39 B
What is Amneal Pharmaceuticals annual revenue year-on-year change?
Over the past year, AMRX annual revenue has changed by +$181.30 M (+8.20%)
What is Amneal Pharmaceuticals quarterly revenue?
The current quarterly revenue of AMRX is $702.47 M
What is the all time high quarterly revenue for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high quarterly revenue is $702.47 M
What is Amneal Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, AMRX quarterly revenue has changed by +$82.43 M (+13.29%)
What is Amneal Pharmaceuticals TTM revenue?
The current TTM revenue of AMRX is $2.68 B
What is the all time high TTM revenue for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high TTM revenue is $2.68 B
What is Amneal Pharmaceuticals TTM revenue year-on-year change?
Over the past year, AMRX TTM revenue has changed by +$294.04 M (+12.32%)